SYRS - Syros Pharmaceuticals, Inc.

QQQ $ 473.83 $ -2.14 (-0.45 %)

DIA $ 417.12 $ -0.26 (-0.06 %)

SPY $ 563.14 $ 0.30 (0.05 %)

TLT $ 100.82 $ -0.51 (-0.5 %)

GLD $ 237.35 $ -1.31 (-0.55 %)

Previous Close

$ 1.98

Open

$ 2.04

Bid

$ 1.99 x 200

Ask

$ 2.01 x 500

Day's Range

$ 1.96 - $ 2.12

52 Week Range

$ 1.43 - $ 8.17

Volume

896,978

Average Volume

Market Cap

52.92M

Beta (5Y Monthly)

$ 0.99

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	07-31-2024	06-30-2024	10-Q
2	05-14-2024	03-31-2024	10-Q
3	03-27-2024	12-31-2023	10-K
4	11-14-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-10-2023	03-31-2023	10-Q
7	03-02-2023	12-31-2022	10-K
8	11-14-2022	09-30-2022	10-Q
9	08-09-2022	06-30-2022	10-Q
10	05-16-2022	03-31-2022	10-Q
11	03-15-2022	12-31-2021	10-K
12	11-05-2021	09-30-2021	10-Q
13	08-05-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	03-04-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-06-2020	06-30-2020	10-Q
18	05-07-2020	03-31-2020	10-Q
19	03-05-2020	12-31-2019	10-K
20	11-12-2019	09-30-2019	10-Q
21	08-01-2019	06-30-2019	10-Q
22	05-01-2019	03-31-2019	10-Q
23	03-07-2019	12-31-2018	10-K
24	11-01-2018	09-30-2018	10-Q
25	08-07-2018	06-30-2018	10-Q
26	05-10-2018	03-31-2018	10-Q
27	03-12-2018	12-31-2017	10-K
28	11-08-2017	09-30-2017	10-Q
29	08-09-2017	06-30-2017	10-Q
30	05-15-2017	03-31-2017	10-Q
31	03-20-2017	12-31-2016	10-K
32	11-14-2016	09-30-2016	10-Q
33	08-15-2016	06-30-2016	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

crude-oil-down-2-paysafe-shares-surge-after-q2-results

Crude Oil Down 2%; Paysafe Shares Surge Af...
08/13/2024 18:30:30

sp-500-gains-1-home-depot-earnings-top-views

S&P 500 Gains 1%; Home Depot Earnings Top ...
08/13/2024 16:15:58

Piper Sandler Reiterates Overweight on Syr...
08/13/2024 15:32:53

Piper Sandler analyst Edward Tenthoff reiterates Syros Pharmaceuticals (NASDAQ:SYRS) with a Overweight and lowers the price ...

nasdaq-surges-200-points-us-producer-prices-increase-01-in-july

Nasdaq Surges 200 Points; US Producer Pric...
08/13/2024 13:54:30

cancer-focused-syros-pharmaceuticals-stops-mid-stage-leukemia-combo-therapy-study-cites-disappointing-unexpected-outcome

Cancer-Focused Syros Pharmaceuticals Stops...
08/13/2024 13:41:17

Syros Pharmaceuticals announces discontinuing enrollment in the SELECT-AML-1 Phase 2 trial due to the low probability of demons...

JMP Securities Maintains Market Outperform...
08/13/2024 11:55:59

JMP Securities analyst Jason Butler maintains Syros Pharmaceuticals (NASDAQ:SYRS) with a Market Outperform and lowers the pr...

HC Wainwright & Co. Maintains Buy on Syros...
08/13/2024 10:57:17

HC Wainwright & Co. analyst Andrew Fein maintains Syros Pharmaceuticals (NASDAQ:SYRS) with a Buy and lowers the price ta...

why-rumble-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket

Why Rumble Shares Are Trading Higher By Ar...
08/13/2024 10:35:23

Trading Halt: Halt status updated at 4:40:...
08/12/2024 20:40:04

Syros To Discontinue Enrollment In SELECT-...
08/12/2024 20:23:13

The companywill discontinue enrollment in the SELECT-AML-1 Phase 2 clinical trial evaluating the triplet regimen of tamibaroten...

Trading Halt: Halted at 4:10:00 p.m. ET - ...
08/12/2024 20:10:04

HC Wainwright & Co. Reiterates Buy on Syro...
08/01/2024 13:11:22

HC Wainwright & Co. analyst Andrew Fein reiterates Syros Pharmaceuticals (NASDAQ:SYRS) with a Buy and maintains $15 pric...

Syros' Cash, Cash Equivalents And Marketab...
07/31/2024 11:32:32

Syros Pharmaceuticals Q2 2024 GAAP EPS $(0...
07/31/2024 10:58:40

HC Wainwright & Co. Reiterates Buy on Syro...
06/26/2024 11:20:57

HC Wainwright & Co. analyst Andrew Fein reiterates Syros Pharmaceuticals (NASDAQ:SYRS) with a Buy and maintains $15 pric...

HC Wainwright & Co. Reiterates Buy on Syro...
05/15/2024 10:56:05

HC Wainwright & Co. analyst Andrew Fein reiterates Syros Pharmaceuticals (NASDAQ:SYRS) with a Buy and maintains $15 pric...

Syros Pharmaceuticals Q1 2024 GAAP EPS $(0...
05/14/2024 10:47:37

Syros Pharmaceuticals (NASDAQ:SYRS) reported quarterly losses of $(0.10) per share which beat the analyst consensus estimate of...

Crude Oil Down Over 1%; Cognyte Software S...
04/09/2024 18:34:43

U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.4% on Tuesday. The Dow traded down 0...

why-tilray-brands-shares-are-trading-lower-by-around-22-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Tilray Brands Shares Are Trading Lower...
04/09/2024 17:12:29

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter esti...

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
04/09/2024 16:31:26